Davis Aaron I. 4
4 · Tango Therapeutics, Inc. · Filed Sep 5, 2024
Insider Transaction Report
Form 4
Davis Aaron I.
DirectorChief Executive Officer
Transactions
- Other
Stock Option (Right to Buy)
2024-09-03+65,000→ 65,000 totalExercise: $10.93Exp: 2034-09-03→ Common Stock (65,000 underlying)
Footnotes (1)
- [F1]This option, which was granted as compensation for consulting services, shall vest and become exercisable in 2 substantially equal installments, with 32,500 shares vesting as of 12/03/2024 and 32,500 shares vesting as of 03/03/2025, subject to the Reporting Person's continuous service with the Issuer as of each such vesting date.